Review
doi: 10.1002/jso.25352.
Epub 2018 Dec 27.
Neoadjuvant Treatments for Advanced Resectable Melanoma
Affiliations
- PMID: 30589079
- DOI: 10.1002/jso.25352
Item in Clipboard
Review
Neoadjuvant Treatments for Advanced Resectable Melanoma
J Surg Oncol.
2019 Jan.
Abstract
Neoadjuvant therapy has demonstrated promise as a treatment modality in resectable advanced-stage melanoma. Treatment has evolved beyond chemotherapy, with the utilization of biochemotherapy, immunotherapy, and targeted therapy in the neoadjuvant setting. These therapies have shown better progression-free survival and melanoma-specific survival when compared with patients that proceed directly to surgery. Ongoing clinical trials will continue to propel research forward to improve the available options for patients with resectable advanced regional disease.
Keywords: melanoma; neoadjuvant treatment.
© 2018 Wiley Periodicals, Inc.
Similar articles
-
Updates in adjuvant systemic therapy for melanoma.J Surg Oncol. 2019 Jan;119(2):222-231. doi: 10.1002/jso.25298. Epub 2018 Nov 27. J Surg Oncol. 2019. PMID: 30481375 Free PMC article. Review.
-
Neoadjuvant therapy for resectable melanoma.Clin Exp Metastasis. 2024 Aug;41(4):461-464. doi: 10.1007/s10585-023-10263-1. Epub 2024 Jan 28. Clin Exp Metastasis. 2024. PMID: 38281255 Free PMC article. Review.
-
Phase II multicenter study of neoadjuvant biochemotherapy for patients with stage III malignant melanoma.J Clin Oncol. 2006 Jul 1;24(19):3157-63. doi: 10.1200/JCO.2005.04.5344. J Clin Oncol. 2006. PMID: 16809738 Clinical Trial.
-
Discontinuation of melanoma combination immunotherapy.Lancet Oncol. 2017 Oct;18(10):e565. doi: 10.1016/S1470-2045(17)30668-X. Epub 2017 Sep 1. Lancet Oncol. 2017. PMID: 28870612 No abstract available.
-
Adjuvant immunotherapy of melanoma and development of new approaches using the neoadjuvant approach.Clin Dermatol. 2013 May-Jun;31(3):237-50. doi: 10.1016/j.clindermatol.2012.08.012. Clin Dermatol. 2013. PMID: 23608443 Free PMC article. Review.
Cited by
-
Mesoporous silica coated spicules for photodynamic therapy of metastatic melanoma.J Nanobiotechnology. 2024 Apr 15;22(1):179. doi: 10.1186/s12951-024-02471-y. J Nanobiotechnology. 2024. PMID: 38616270 Free PMC article.
-
Efficacy of Neoadjuvant Targeted Therapy for Borderline Resectable III B-D or IV Stage BRAF V600 Mutation-Positive Melanoma.Cancers (Basel). 2021 Dec 27;14(1):110. doi: 10.3390/cancers14010110. Cancers (Basel). 2021. PMID: 35008274 Free PMC article.
-
Neoadjuvant Pembrolizumab and High-Dose IFNα-2b in Resectable Regionally Advanced Melanoma.Clin Cancer Res. 2021 Aug 1;27(15):4195-4204. doi: 10.1158/1078-0432.CCR-20-4301. Epub 2021 Mar 22. Clin Cancer Res. 2021. PMID: 33753453 Free PMC article.
-
Construction, validation and, visualization of a web-based nomogram to identify the best candidates for primary tumor resection in advanced cutaneous melanoma patients.Front Surg. 2023 Jan 18;9:975690. doi: 10.3389/fsurg.2022.975690. eCollection 2022. Front Surg. 2023. PMID: 36743900 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
